Registry collecting lung function test results in children with respiratory disease
Stores lung function test results from children with cystic fibrosis or respiratory disease.
Plain-language title generated from the registry record
Registry title: Measures of Respiratory Health Registry
Key facts
- Where
- Vancouver, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 99 years old?
Source: NCT05501587, who can take part
Where in Canada
- British Columbia Children's HospitalVancouver, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of British Columbia
- Trial code
- NCT05501587
- Record updated
- 15 August 2022
- Original description
There are many techniques that can allow for the quantification of lung function in children; some are being used clinically and others are under development. Many of these tools are available at BC Children's Hospital. This registry study will act as a central repository for the results of traditional and novel pulmonary function tests done at BC Children's Hospital to allow for future analysis.Read full original descriptionShow less
Measures of Respiratory Health Registry
There are many techniques that can allow for the quantification of lung function in children; some are being used clinically and others are under development. Many of these tools are available at BC Children's Hospital. This registry study will act as a central repository for the results of traditional and novel pulmonary function tests done at BC Children's Hospital to allow for future analysis.
Inclusion: -Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria: i. A documented sweat chloride ≥ 60 mEq/L by quantitative pilocarpine iontophoresis (QPIT); A documented genotype with two disease-causing mutations in the CFTR gene; In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing; Physician-diagnosed lung disease; Informed consent by participant, parent, or legal guardian; In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing.
Exclusion: Requirement of supplementary oxygen to maintain oxygen saturation above 95%; Participants with other Respiratory Disease; Evidence of lung disease; Physical findings at the screening that would compromise the safety of the participant or the quality of the data (e.g. respiratory distress or work of breathing); Physical findings at screening that would compromise the safety of the participant or the quality of the research data; Requirement of supplementary oxygen to maintain oxygen saturation above 95%; Healthy Participants; Inclusion criteria; Informed consent by participant, parent, or legal guardian; In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing; Physical findings at screening that would compromise the safety of the participant or the quality of the research data.
Participants with CF.